Benoît Brilland

606 total citations
36 papers, 322 citations indexed

About

Benoît Brilland is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Immunology. According to data from OpenAlex, Benoît Brilland has authored 36 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 16 papers in Nephrology and 12 papers in Immunology. Recurrent topics in Benoît Brilland's work include Vasculitis and related conditions (18 papers), Renal Diseases and Glomerulopathies (15 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Benoît Brilland is often cited by papers focused on Vasculitis and related conditions (18 papers), Renal Diseases and Glomerulopathies (15 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Benoît Brilland collaborates with scholars based in France, Canada and United States. Benoît Brilland's co-authors include Jean‐François Augusto, Jean‐François Subra, Alain Chevailler, Pascale Jeannin, Anne‐Sophie Garnier, Anne Croué, Agnès Duveau, Nicolás Henry, Julien Demiselle and Giorgina Barbara Piccoli and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and Frontiers in Immunology.

In The Last Decade

Benoît Brilland

30 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benoît Brilland France 11 179 135 115 74 57 36 322
Shane A. Bobart United States 9 118 0.7× 33 0.2× 236 2.1× 37 0.5× 35 0.6× 28 296
Н А Мухин Russia 7 89 0.5× 28 0.2× 83 0.7× 33 0.4× 33 0.6× 53 221
Gaofu Zhang China 11 150 0.8× 71 0.5× 209 1.8× 21 0.3× 77 1.4× 33 353
David Hooke Australia 6 79 0.4× 131 1.0× 210 1.8× 20 0.3× 61 1.1× 7 389
Alexander Magil Canada 7 122 0.7× 52 0.4× 145 1.3× 56 0.8× 27 0.5× 8 310
U. Kneissler Germany 10 162 0.9× 202 1.5× 287 2.5× 36 0.5× 86 1.5× 21 549
Hee Yeon Cho South Korea 11 67 0.4× 71 0.5× 184 1.6× 26 0.4× 64 1.1× 13 328
Georg Schumm Germany 5 93 0.5× 61 0.5× 230 2.0× 26 0.4× 23 0.4× 6 365
F. Amorós Spain 9 41 0.2× 65 0.5× 41 0.4× 23 0.3× 63 1.1× 27 221
Zheng Tang China 10 109 0.6× 57 0.4× 215 1.9× 13 0.2× 42 0.7× 25 288

Countries citing papers authored by Benoît Brilland

Since Specialization
Citations

This map shows the geographic impact of Benoît Brilland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Brilland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Brilland more than expected).

Fields of papers citing papers by Benoît Brilland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Brilland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Brilland. The network helps show where Benoît Brilland may publish in the future.

Co-authorship network of co-authors of Benoît Brilland

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Brilland. A scholar is included among the top collaborators of Benoît Brilland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Brilland. Benoît Brilland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florens, Nans, Mehdi Maanaoui, Antoine Lanot, et al.. (2025). ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training. Clinical Kidney Journal. 18(10). sfaf308–sfaf308. 1 indexed citations
2.
Brilland, Benoît, Jérémie Riou, Nathalie Merillon, et al.. (2025). Identification of Renal Transcripts Associated with Kidney Function and Prognosis in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 37(1). 131–149. 1 indexed citations
3.
Gatault, Philippe, Léonard Golbin, Antoine Thierry, et al.. (2025). Outcomes After Kidney Transplantation in Antineutrophil Cytoplasmic Autoantibody–Associated Renal Vasculitis. Kidney International Reports. 10(10). 3465–3483. 1 indexed citations
4.
Brilland, Benoît, Jean‐François Augusto, P.A. Michel, Noémie Jourde‐Chiche, & Cécile Couchoud. (2025). Kidney Transplantation Improves Survival in Lupus Nephritis With End-Stage Kidney Disease. Kidney International Reports. 10(4). 1163–1174.
5.
Zhu, Shirley, Benoît Brilland, Dieter P. Reinhardt, et al.. (2024). Cytokine priming enhances the antifibrotic effects of human adipose derived mesenchymal stromal cells conditioned medium. Stem Cell Research & Therapy. 15(1). 329–329. 2 indexed citations
6.
Brilland, Benoît, Simon Blanchard, Odile Blanchet, et al.. (2023). #4027 KIDNEY INJURY MOLECULE 1 (KIM-1): A POTENTIAL BIOMARKER OF ACUTE KIDNEY INJURY AND TUBULOINTERSTITIAL INJURY IN PATIENTS WITH ANCA-GLOMERULONEPHRITIS. Nephrology Dialysis Transplantation. 38(Supplement_1).
7.
Augusto, Jean‐François & Benoît Brilland. (2023). Physiopathologie des vascularites à ANCA. Néphrologie & Thérapeutique. 19(S1). 30–38.
8.
Fortrat, Jacques‐Olivier, et al.. (2023). Post-traumatic hypertension: when nerves break down. Journal of Nephrology. 36(9). 2629–2632.
9.
Brilland, Benoît, Simon Blanchard, Odile Blanchet, et al.. (2023). Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis. Clinical Kidney Journal. 16(9). 1521–1533. 22 indexed citations
10.
Brilland, Benoît, Marie‐Christine Copin, Nicolás Henry, et al.. (2022). Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis. Frontiers in Immunology. 13. 834878–834878. 10 indexed citations
11.
Joseph, Adrien, Benoît Brilland, Laure Burguet, et al.. (2022). Predictive Scores for Early Identification of Immune-Mediated Thrombotic Thrombocytopenic Purpura: Room for Improvement?. Kidney International Reports. 7(11). 2541–2542. 1 indexed citations
12.
Fage, Nicolas, et al.. (2022). Thrombotic microangiopathy with mild renal involvement and profound thrombocytopenia: not all roads lead to thrombotic thrombocytopenic purpura. Journal of Nephrology. 35(4). 1271–1273. 1 indexed citations
13.
Copin, M.C., et al.. (2022). Histopathological prognostic factors in ANCA-associated glomerulonephritis.. Autoimmunity Reviews. 21(9). 103139–103139. 12 indexed citations
14.
Fage, Nicolas, Corentin Orvain, Nicolás Henry, et al.. (2021). Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome. Kidney International Reports. 7(2). 221–231. 17 indexed citations
15.
Brilland, Benoît, Assia Djema, Jean‐Philippe Coindre, et al.. (2021). Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients. Kidney International Reports. 6(4). 1161–1165. 5 indexed citations
16.
Brilland, Benoît, et al.. (2021). Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?. Kidney International Reports. 6(11). 2931–2933. 4 indexed citations
17.
Brilland, Benoît, Julien Demiselle, Agnès Duveau, et al.. (2020). Renal biopsy in very elderly patients (over 80 years): clinical presentation, histological diagnosis, and long-term outcome. International Urology and Nephrology. 52(4). 721–729. 1 indexed citations
18.
Brilland, Benoît, Marc Scherlinger, Liliane Khoryati, et al.. (2019). Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus. Clinical Reviews in Allergy & Immunology. 58(2). 194–212. 19 indexed citations
19.
Brilland, Benoît, Anne‐Sophie Garnier, Alain Chevailler, et al.. (2019). Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside. Autoimmunity Reviews. 19(1). 102424–102424. 54 indexed citations
20.
Augusto, Jean‐François, Julien Demiselle, Christian Lavigne, et al.. (2016). Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis. PLoS ONE. 11(7). e0158871–e0158871. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shane A. Bobart Breakdown of academic impact, for papers by Н А Мухин Breakdown of academic impact, for papers by Gaofu Zhang Breakdown of academic impact, for papers by David Hooke Breakdown of academic impact, for papers by Alexander Magil Breakdown of academic impact, for papers by U. Kneissler Breakdown of academic impact, for papers by Hee Yeon Cho Breakdown of academic impact, for papers by Georg Schumm Breakdown of academic impact, for papers by F. Amorós Breakdown of academic impact, for papers by Zheng Tang
Rankless by CCL
2026